GC treatment who have had an osteoporotic fracture â‰¥12 months after starting OP therapy, or who have had a significant loss of BMD (eg, greater than the least significant change per their DXA machine) after 1 to 2 years of OP treatment, we conditionally recommend changing to another class of OP medication over not switching the class of OP medication (PICO 10.1-10.9). If oral BP is the first OP therapy and suboptimal adherence or poor absorption is suspected, based on low certainty evidence, we